ARIAD Presents Updated Clinical Data on Its Investigational Pan-BCR-ABL Inhibitor, AP24534, in Drug-Resistant Chronic Myeloid Leukemia http://finance.yahoo.com/news/ARIAD-Presents-Updated-bw-1341332663.html?x=0&.v=1